HYQVIA/HyQvia
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HYQVIA/HyQvia, covering 2023-12-14 to 2023-12-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants [Phase 1]